A guide to the use of psychoactive agents.
D000661:Amphetamine / Q000627:therapeutic use; D000928:Antidepressive Agents / Q000009:adverse effects / Q000627:therapeutic use*; D002090:Butyrophenones / Q000627:therapeutic use; D003984:Dibenzazepines / Q000627:therapeutic use; D003990:Dibenzoxepins / Q000009:adverse effects / Q000145:classification; D004565:Electroconvulsive Therapy; D006801:Humans; D008094:Lithium / Q000627:therapeutic use; D010640:Phenothiazines / Q000009:adverse effects / Q000145:classification / Q000627:therapeutic use*; D008517:Phytotherapy; D010946:Plants, Medicinal; D011926:Rauwolfia / Q000627:therapeutic use; D014149:Tranquilizing Agents / Q000009:adverse effects / Q000627:therapeutic use*; D014966:Xanthenes / Q000627:therapeutic use
D000928:Antidepressive Agents; D002090:Butyrophenones; D003984:Dibenzazepines; D003990:Dibenzoxepins; D010640:Phenothiazines; D014149:Tranquilizing Agents; D014966:Xanthenes; D008094:Lithium; D000661:Amphetamine